Delivery Order SPE2DB20D1100-SPE2DB25FD7U6
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,072.56 to AmerisourceBergen Drug Corp for Clindamycin Phosphate 1% Foam 50GM, a topical antibiotic pharmaceutical product. This competitive, non-set-aside contract award was executed on August 7, 2025, with an ultimate completion date of August 8, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract operates under a firm fixed-price delivery order structure,...
- The Defense Logistics Agency awarded a delivery order valued at $1,450.14 to AmerisourceBergen Drug Corp for Clindamycin Phosphate 1% Foam 50GM, a topical antibiotic medication. This non-set-aside, competitively awarded contract reflects a firm fixed price arrangement with an ultimate completion date of August 5, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Clindamycin Phosphate 1% Foam in 50-gram units, valued at $1,315.27. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by August 8, 2025. The order will be fulfilled from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its principal...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,393.56 firm fixed-price contract is for the supply of Clindamycin Phosphate 1% Foam, a topical antibiotic medication. The contract has a performance period through May 31, 2023 and was awarded on May 30, 2023. This delivery order is issued under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract with DLA Troop Support Medical, which provides...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4565366325 - Clindamycin Phosphate 1% Foam, 50 gm. The order has a firm fixed-price of $2,838.07 and the period of performance runs through August 7, 2024. As a major pharmaceutical distributor, AmerisourceBergen provides a wide range of prescription medications, over-the-counter drugs, and medical supplies to support various government agencies and healthcare programs,...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,835.36, is for the delivery of Clindamycin Phosphate 1% Foam in 100 gram quantities. The contract is a firm fixed-price delivery order, with an ultimate completion date of July 9, 2025. This contract award is not designated as a set-aside, indicating open competition....
- This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4560408677 - Clindamycin Phosphate 1% Foam 50GM, with a ceiling value of $2,433.39 and a completion date of March 29, 2023. This Delivery Order is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Clindamycin Phosphate 1% Foam, 100 grams, with a ceiling value of $1,217.44 and a performance period through June 10, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00,...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Clindamycin Phosphate 1% Foam in 50 gram units. The contract has a ceiling value of $1,671.89 and a completion date of July 9, 2025. It is a Firm Fixed Price Delivery Order contract, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
- This federal contract award, valued at $2,969.13, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567090332 - Clindamycin Phosphate 1% Foam 100GM, a pharmaceutical product, with a completion date of January 30, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FD7U6Delivery Order
AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency valued at $2,491.58 for Clindamycin Phosphate 1% Foam 50GM, a topical antibiotic medication. The contract was awarded on July 31, 2025, with an ultimate completion date of August 1, 2025, and represents a firm fixed-price procurement with no set-aside designation. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime vendor agreement extending through December 2026 that serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. The DLA Medical Supply Chain utilizes this prime vendor contract to procure a broad range of pharmaceutical products and medical supplies to support Defense Health Agency operations and other federal healthcare systems worldwide. This specific delivery order exemplifies the routine pharmaceutical supply chain fulfillment that occurs under this larger strategic contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 7/31/25 |